Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

672 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical implications of early caudate dysfunction in Parkinson's disease.
Pasquini J, Durcan R, Wiblin L, Gersel Stokholm M, Rochester L, Brooks DJ, Burn D, Pavese N. Pasquini J, et al. Among authors: brooks dj. J Neurol Neurosurg Psychiatry. 2019 Oct;90(10):1098-1104. doi: 10.1136/jnnp-2018-320157. Epub 2019 May 11. J Neurol Neurosurg Psychiatry. 2019. PMID: 31079063 Free PMC article.
Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment.
Brooks DJ, Agid Y, Eggert K, Widner H, Ostergaard K, Holopainen A; TC-INIT Study Group. Brooks DJ, et al. Eur Neurol. 2005;53(4):197-202. doi: 10.1159/000086479. Epub 2005 Jun 20. Eur Neurol. 2005. PMID: 15970632 Clinical Trial.
672 results